{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:02:12Z","timestamp":1787169732616,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study was performed to determine the genotype and allelic frequencies (polymorphisms) of the four genes of vitamin D receptor (VDR) among Egyptian psoriatic patients and healthy controls to explore their association with disease severity (PASI) score and immune modulation of IL-22 cytokine and to predict the response to topical calcipotriol treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>The frequencies of the four VDR gene polymorphisms (FokI, ApaI, TaqI, and BsmI) in blood samples of 51 adult Egyptian patients with psoriasis vulgaris and 50 healthy controls were evaluated using restriction fragment length polymorphism (RFLP)-PCR. Serum levels of IL-22 were measured by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The most frequent genotype (wild) in the studied patients was Apa1; AA (88.2%) followed by Fok1; FF (47.1%) and Taq1; TT (47%), while Bsm1; BB genotype was (27.7%). The most frequent allele polymorphisms either in one allele (Bb) or both alleles (bb) in psoriatic patients were 72.5%, followed by Ff, ff (52.9%) and Tt, tt (52.9%). The less frequent allelic polymorphism was Aa, aa (27.7%). Insignificant differences in the frequency of genotype (wild) and allelic polymorphisms were detected between patients and controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). A significantly higher serum concentration of IL-22 (ng\/mL) was detected in patients than controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). Further, 66.6% of patients displayed a clinical response, while 33.4% were non-responders. A significantly higher expression of TaqI polymorphism was detected in (100%) of non-responders (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), which was also correlated with disease severity (r = 0.515,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These results suggest that the VDR TaqI polymorphism is the only gene correlated to psoriasis susceptibility in the Egyptian population, and affects the response to topical calcipotriol treatment but does not affect IL-22 immune modulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_799_21","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T09:08:31Z","timestamp":1649927311000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Frequency of Genotypes and Allelic Polymorphisms of Vitamin D Receptor in Egyptian Psoriatic Patients and Their Association With Disease Severity, Immune Modulation of IL-22 Levels and The Response to Topical Calcipotriol Treatment"],"prefix":"10.4103","volume":"67","author":[{"given":"Haneya A.","family":"A. Anani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warda A.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza Ali","family":"Althoqapy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheir S.","family":"Maklad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Samir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240829","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-7-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate-severe psoriasis: A European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"R3-7-20240829","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Identification and management of psoriasis and associated comorbidity (IMPACT) project team. Global epidemiology of psoriasis: A systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Investig Dermatol"},{"key":"R4-7-20240829","first-page":"105","article-title":"Genetic determinants of bone mass","volume":"51","author":"Audi","year":"1999","journal-title":"Horm Res"},{"key":"R5-7-20240829","first-page":"187","article-title":"Vitamin D endocrine system and psoriasis vulgaris--review of the literature","volume":"17","author":"Rucevi\u0107","year":"2009","journal-title":"Acta Dermatovenerol Croat"},{"key":"R6-7-20240829","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00403-007-0782-5","article-title":"Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients","volume":"299","author":"Dayangac-Erden","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"R7-7-20240829","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/nu5072502","article-title":"Vitamin D and immune function","volume":"5","author":"Prietl","year":"2013","journal-title":"Nutrients"},{"key":"R8-7-20240829","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of Vitamin D on human health and disease","volume":"12","author":"Charoenngam","year":"2020","journal-title":"Nutrients"},{"key":"R9-7-20240829","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsbmb.2013.12.009","article-title":"Regulation of the extrarenal CYP27B1-hydroxylase","volume":"144","author":"Adams","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R10-7-20240829","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"R11-7-20240829","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"R12-7-20240829","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"R13-7-20240829","first-page":"1","article-title":"Targeting IL-23 in psoriasis: Current perspectives","volume":"8","author":"Fotiadou","year":"2018","journal-title":"Psoriasis (Auckl"},{"key":"R14-7-20240829","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","article-title":"Genetic and epigenetic basis of psoriasis pathogenesis","volume":"64","author":"Chandra","year":"2015","journal-title":"Mol Immunol"},{"key":"R15-7-20240829","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jcot.2019.07.004","article-title":"Vitamin D for skeletal and non-skeletal health: What we should know","volume":"10","author":"Charoenngam","year":"2019","journal-title":"J Clin Orthop Trauma"},{"key":"R16-7-20240829","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis oral therapy with a new retinoid","volume":"157","author":"Fredericksson","year":"1978","journal-title":"Dermatologica"},{"key":"R17-7-20240829","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2003.09.014","article-title":"A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis","volume":"50","author":"Carlin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R18-7-20240829","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0961203311422709","article-title":"Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population","volume":"21","author":"Luo","year":"2014","journal-title":"Lupus"},{"key":"R19-7-20240829","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2230.2010.03970.x","article-title":"A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis","volume":"36","author":"Zuel-Fakkar","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R20-7-20240829","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00403-002-0314-2","article-title":"Polymorphism of the vitamin D3 receptor in patients with psoriasis","volume":"294","author":"Okita","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"R21-7-20240829","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2013.08.014","article-title":"The association of polymorphisms of the vitamin D receptor gene with psoriasis in the Han population of northeastern China","volume":"73","author":"Zhou","year":"2014","journal-title":"J Dermatol Sci"},{"key":"R22-7-20240829","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01213011-200505000-00011","article-title":"Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility inpsoriasis","volume":"15","author":"Halsall","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R23-7-20240829","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2012.01.040","article-title":"Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study","volume":"67","author":"Orgaz-Molina","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R24-7-20240829","doi-asserted-by":"crossref","first-page":"5237642","DOI":"10.1155\/2019\/5237642","article-title":"The Clinical effect of oral vitamin D2 supplementation on psoriasis: A double-blind, randomized, placebo-controlled study","volume":"2019","author":"Disphanurat","year":"2019","journal-title":"Dermatol Res Pract"},{"key":"R25-7-20240829","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: Immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"R26-7-20240829","doi-asserted-by":"crossref","first-page":"223ra22","DOI":"10.1126\/scitranslmed.3007217","article-title":"Integrative biology approach identifies cytokine targeting strategies for psoriasis?","volume":"6","author":"Perera","year":"2014","journal-title":"Sci Transl Med"},{"key":"R27-7-20240829","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.4049\/jimmunol.1700021","article-title":"Limited presence of IL-22 binding protein, a natural IL-22 inhibitor, strengthens psoriatic skin inflammation","volume":"198","author":"Martin","year":"2017","journal-title":"J Immunol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_799_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:36Z","timestamp":1787166756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_799_21"}},"subtitle":["A Case Control Study"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_799_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}